Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
International Journal of Oncology|October 27, 2018
The novel prognostic marker, EHMT2, is involved in cell proliferation via HSPD1 regulation in breast cancerSeon-Kyu Kim, Kwangho Kim, Jea-Woon Ryu, et al.Experimental Hematology & Oncology|August 19, 2024
Epigenetic alterations of TP53INP1 by EHMT2 regulate the cell cycle in gastric cancerTae Young Ryu, In Hwan Tae, Tae-Su Han, et al.Nature Communications|November 12, 2025
YTHDF2 regulates self non-coding RNA metabolism to control inflammation and tumorigenesisSeungwon Yang, Yan-Hong Cui, Haixia Li, et al.Experimental & Molecular Medicine|March 5, 2026
Gut microbiota modulation of epigenetic target EHMT2: Lacticaseibacillus rhamnosus Fb7-311 regulated renal cell carcinoma apoptosis and metastasisJeongmin Lee, Jinkwon Lee, In Hwan Tae, et al.Experimental & Molecular Medicine|April 30, 2023
Epigenetic regulation of SMAD3 by histone methyltransferase SMYD2 promotes lung cancer metastasisKwangho Kim, Tae Young Ryu, Eunsun Jung, et al.Theranostics|April 21, 2020
Low-dose interleukin-2 alleviates dextran sodium sulfate-induced colitis in mice by recovering intestinal integrity and inhibiting AKT-dependent pathwaysHana Lee, Ye Seul Son, Mi-Ok Lee, et al.Signal Transduction and Targeted Therapy|May 17, 2026
Targeting EHMT2 overcomes 5-fluorouracil resistance in colorectal cancer by modulating cell cycle and apoptosisIn Hwan Tae, Yunsang Kang, Jinkwon Lee, et al.The ISME Journal|January 1, 2022
Human gut-microbiome-derived propionate coordinates proteasomal degradation via HECTD2 upregulation to target EHMT2 in colorectal cancerTae Young Ryu, Kwangho Kim, Tae-Su Han, et al.Pageof 2